drugset / Trial / NCT05761444
Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to confirm the effectiveness of ezetimibe add-on therapy on LDL-C levels compared to atorvastatin monotherapy, especially in very high-risk patients. We intend to lay the foundation for a standard treatment for these patients through ezetimibe add on lipid-lowering therapy.
Timeline
- Start
- 2023-07-26
- Primary completion
- 2024-09-04
- Completion
- 2024-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 40 mg | Oral |
| Comparator | Atorvastatin | Small molecule | 80 mg | Oral |
| Subject | Ezetimibe | Unknown | 10 mg | Oral |